Bariatric surgery and precision nutrition

Nutrients

Volumn 9, Issue 9, 2017, Pages 1-13

  Nicoletti, Carolina F ^a   Cortes Oliveira, Cristiana ^a   Pinhel, Marcela A S ^a,b   Nonino, Carla B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Sao Jose do Rio Preto Medical School   (Brazil)

Author keywords

Bariatric surgery; Biomarkers; DNA methylation; Epigenetics; Gene; Gene expression; Microbiota; Obesity; Polymorphism

Indexed keywords

ADENOSINE KINASE; ALPHA KETOGLUTARATE DEPENDENT DIOXYGENASE FTO; BIOLOGICAL MARKER; FATTY ACID SYNTHASE; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; LYSOPHOSPHOLIPASE; MELANOCORTIN 4 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN TYROSINE PHOSPHATASE; PYRUVATE DEHYDROGENASE KINASE 4; SEROTONIN RECEPTOR; TRANSCRIPTION FACTOR FOXP2; UNCOUPLING PROTEIN 2; TRANSCRIPTOME;

BARIATRIC SURGERY; BODY MASS; BODY WEIGHT MANAGEMENT; DIETARY INTAKE; DNA METHYLATION; EPIGENETICS; FEEDING BEHAVIOR; GASTRIC BANDING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HUMAN; INTESTINE FLORA; NONHUMAN; NUTRIGENOMICS; OBESITY; REVIEW; ROUX-EN-Y GASTRIC BYPASS; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEVE GASTRECTOMY; TELOMERE SHORTENING; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT LOSS; CALORIC RESTRICTION; ENERGY METABOLISM; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PHENOTYPE; TREATMENT OUTCOME;

ANIMALS; BARIATRIC SURGERY; CALORIC RESTRICTION; DNA METHYLATION; ENERGY METABOLISM; EPIGENESIS, GENETIC; GASTROINTESTINAL MICROBIOME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NUTRIGENOMICS; NUTRITIONAL STATUS; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECISION MEDICINE; TRANSCRIPTOME; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 85029142507     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9090974     Document Type: Review

References (98)

1. Hao, Z.; Mumphrey, M.B.; Morrison, C.D.; Münzberg, H.; Ye, J.; Berthoud, H.R. Does gastric bypass surgery change body weight set point? Int. J. Obes. Suppl. 2016, 6, S37-S43.
2. Schauer, P.R.; NorHanipah, Z.; Rubino, F.Metabolic surgery for treating type 2 diabetesmellitus: Nowsupported by the world’s leading diabetes organizations. Clevel. Clin. J.Med. 2017, 84, S47-S56.
3. Busetto, L.; Dixon, J.; De Luca, M.; Shikora, S.; Pories, W.; Angrisani, L. Bariatric surgery in class I obesity: A position statement from the international federation for the surgery of obesity and metabolic disorders (IFSO). Obes. Surg. 2014, 24, 487-519.
4. Angrisani, L.; Santonicola, A.; Iovino, P.; Formisano, G.; Buchwald, H.; Scopinaro, N. Bariatric surgery world wide 2013. Obes. Surg. 2015, 25, 1822-1832.
5. Schauer, P.R.; Mingrone, G.; Ikramuddin, S.; Wolfe, B. Clinical outcomes of metabolic surgery: Efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care 2016, 39, 902-911.
6. Khorgami, Z.; Andalib, A.; Corcelles, R.; Aminian, A.; Brethauer, S.; Schauer, P. Recent national trends in the surgical treatment of obesity: Sleeve gastrectomy dominates. Surg. Obes. Relat. Dis. 2015, 11, S1-S34.
7. Buchwald, H.; Avidor, Y.; Braunwald, E.; Jensen, M.D.; Pories, W.; Fahrbach, K.; Schoelles, K. Bariatric surgery: A systematic review and meta-analysis. JAMA 2004, 292, 1724-1737.
8. Nicoletti, C.F.; de Oliveira, B.A.P.; Pinhel, M.A.S.; Donati, B.; Marchini, J.S.; Salgado-Junior, W.; Nonino, C.B. Influence of excess weight loss and weight regain on biochemical indicators during a 4-year follow-up after Roux-en-Y gastric bypass. Obes. Surg. 2015, 25, 279-284.
9. Cooper, T.C.; Simmons, E.B.; Webb, K.; Burns, J.L.; Kushner, R.F. Trends in weight regain following Rouxen-Y gastric bypass (RYGB) bariatric surgery. Obes. Surg. 2015, 25, 1474-1481.
10. Magro, D.O.; Geloneze, B.; Delfini, R.; Pareja, B.C.; Callejas, F.; Pareja, J.C. Long-term weight regain after gastric bypass: A 5-year prospective study. Obes. Surg. 2008, 18, 648-651.
11. Still, C.D.; Wood, G.C.; Chu, X.; Erdman, R.; Manney, C.H.; Benotti, P.N.; Petrick, A.T.; Strodel, W.E.; Mirshahi, U.L.; Mirshahi, T.; et al. High allelic burden of four obesity SNPs is associated with poorer weight loss outcomes following gastric bypass surgery. Obesity 2011, 19, 1676-1683.
12. Hainer, V.; Zamrazilova, H.; Spalova, J.; Hainerova, I.; Kunesova, M.; Aldhoon, B.; Bendlová, B. Role of hereditary factors in weight loss and its maintenance. Phys. Res. 2008, 57, S1-S15.
13. Kashyap, S.R.; Gatmaitan, P.; Brethauer, S.; Schauer, P. Bariatric surgery for type 2 diabetes: Weighing the impact for obese patients. Clevel. Clin. J. Med. 2010, 77, 468-476.
14. De Luis, D.A.; Sagrado, M.G.; Pacheco, D.; Terroba, M.C.; Martin, T.; Cuellar, L.; Ventosa, M. Effect of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery. Surg. Obes. Relat. Dis. 2010, 6, 516-520.
15. Ferguson, L.R.; De Caterina, R.; Görman, U.; Allayee, H.; Kohlmeier, M.; Prasad, C.; Choi, M.S.; Curi, R.; de Luis, D.A.; Gil, Á.; et al. Guide and position of the International Society of Nutrigenetics/Nutrigenomics on personalised nutrition: Part 1—Fields of precision nutrition. J. Nutrigenet. Nutrigenom. 2016, 9, 12-27.
16. Kaput, J.; Astley, S.; Renkema, M.; Ordovas, J.; van Ommen, B. Harnessing Nutrigenomics: Development of web-based communication, databases, resources, and tools. Genes Nutr. 2006, 1, 5-11.
17. Peña-Romero, A.C.; Navas-Carrillo, D.; Marín, F.; Orenes-Piñero, E. The future of nutrition: nutrigenomics and nutrigenetics in obesity and cardiovascular diseases. Crit. Rev. Food Sci. Nutr. 2017, 5.
18. Simopoulos, A.P. Nutrigenetics/nutrigenomics. Annu. Rev. Public Health 2010, 31, 53-68.
19. Martínez, J.A. Perspectives on personalized nutrition for obesity. Nutrigenet. Nutrigenom. 2014, 7.
20. Kovolou, G.D.; Kolovou, V.; Papadopoulou, A.; Watts, G.F. MTP gene variants and response to lomitapide in patients with homozygous familial hypercholesterolemia. J. Atheroscler. Thromb. 2016, 23, 878-883.
21. Resende, C.M.M.; Durso, D.F.; Borges, K.B.G.; Pereira, R.M.; Rodrigues, G.K.D.; Rodrigues, K.F.; Silva, J.L.P.; Rodrigues, E.C.; Franco, G.R.; Alvarez-Leite, J.I. The polymorphism rs17782313 near MC4R gene is related with anthropometric changes in women submitted to bariatric surgery over 60 months. Clin. Nutr. 2017.
22. Nicoletti, C.F.; de Oliveira, A.P.; Brochado, M.J.; Pinhel, M.A.; de Oliveira, B.A.; Marchini, J.S.; Dos Santos, J.E.; Salgado, W.; Jr.; Cury, N.M.; de Araújo, L.F.; et al. The Ala55Val and -866G > A polymorphisms of the UCP2 gene could be biomarkers for weight loss in patients who had Roux-en-Y gastric bypass. Nutrition 2017, 33, 326-330.
23. De Luis, D.A.; Izaola, O.; Primo, D.; Pacheco, D. Effect of the rs10767664 Variant of the brain-derived neurotrophic factor gene on weight change and cardiovascular risk factors in morbidly obese patients after biliopancreatic diversion surgery. J. Nutrigenet. Nutrigenom. 2016, 9, 116-122.
24. Novais, P.F.; Weber, T.K.; Lemke, N.; Verlengia, R.; Crisp, A.H.; Rasera-Junior, I.; de Oliveira, M.R. Gene polymorphisms as a predictor of body weight loss after Roux-en-Y gastric bypass surgery among obese women. Obes. Res. Clin. Pract. 2016, 10, 724-727.
25. Hartmann, I.B.; Fries, G.R.; Bücker, J.; Scotton, E.; von Diemen, L.; Kauer-Sant’Anna, M. The FKBP5 polymorphism rs1360780 is associated with lower weight loss after bariatric surgery: 26 months of follow-up. Surg. Obes. Relat. Dis. 2016, 12, 1554-1560.
26. Seip, R.L.; Papasavas, P.; Stone, A.; Thompson, S.; Ng, J.; Tishler, D.S.; Ruaño, G. Comparative physiogenomic analyses of weight loss in response to 2 modes of bariatric surgery: Demonstration with candidate neuropsychiatric and cardiometabolic genes. Surg. Obes. Relat. Dis. 2016, 12, 369-377.
27. Vitolo, E.; Santini, E.; Seghieri, M.; Giannini, L.; Coppedè, F.; Rossi, C.; Dardano, A.; Solini, A. Heterozygosity for the rs696217 SNP in the preproghrelin gene predicts weight loss after bariatric surgery in severely obese individuals. Obes. Surg. 2017, 27, 961-967.
28. Figueroa-Veja, N.; Jordán, B.; Pérez-Luque, E.L.; Parra-Laporte, L.; Garnelo, S.; Malacara, J.M. Effects of sleeve gastrectomy and rs9930506 FTO variants on angiopoietin/Tie-2 system in fat expansion and M1 macrophages recruitment in morbidly obese subjects. Endocrine 2016, 54, 700-713.
29. Krawczyk, M.; Jiménez-Agüero, R.; Alustiza, J.M.; Emparanza, J.I.; Perugorria, M.J.; Bujanda, L.; Lammert, F.; Banales, J.M. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery. Surg. Obes. Relat. Dis. 2016, 12, 1838-1846.
30. Nicoletti, C.F.; Pinhel, M.A.; de Oliveira, B.A.; Marchini, J.S.; Salgado Junior, W.; Silva Junior, W.A.; Nonino, C.B. The genetic predisposition score of seven obesity-related single nucleotide polymorphisms is associated with better metabolic outcomes after Roux-en-Y gastric bypass. J. Nutrigenet. Nutrigenom. 2016, 9, 222-230.
31. Bandstein, M.; Mwinyi, J.; Ernst, B.; Thurnheer, M.; Schultes, B.; Schiöth, H.B. A genetic variant in proximity to the gene LYPLAL1 is associated with lower hunger feelings and increased weight loss following Roux-en-Y gastric bypass surgery. Scand. J. Gastroenterol. 2016, 51, 1050-1055.
32. Rodrigues, G.K.; Resende, C.M.; Durso, D.F.; Rodrigues, L.A.; Silva, J.L.; Reis, R.C.; Pereira, S.S.; Ferreira, D.C.; Franco, G.R.; Alvarez-Leite, J. A single FTO gene variant rs9939609 is associated with body weight evolution in a multiethnic extremely obese population that underwent bariatric surgery. Nutrition 2015, 31, 1344-1350.
33. Jia, P.; Her, C.; Chai, W. DNA excision repair at telomeres. DNA Repair 2015, 36, 137-145.
34. Blackburn, E.H. Telomeres and telomerase: The means to the end (Nobel lecture). Angew. Chem. Int. Ed. Eng. 2010, 49, 7405-7421.
35. Barceló, A.; Piérola, J.; López-Escribano, H.; de la Peña, M.; Soriano, J.B.; Alonso-Fernández, A.; Ladaria, A.; Agustí, A. Telomere shortening in sleep apnea syndrome. Respir. Med. 2010, 104, 1225-1229.
36. Lee, M.; Martin, H.; Firpo, M.A.; Demerath, E.W. Inverse association between adiposity and telomere length: The fels longitudinal study. Am. J. Hum. Biol. 2010, 23, 100-106.
37. Dersham, R.; Chu, X.; Wood, G.C.; Benotti, P.; Still, C.D.; Rolston, D.D. Changes in telomere length 3-5 years after gastric bypass surgery. Int. J. Obes. 2017.
38. Wong, J.M.; Collins, K. Telomere maintenance and disease. Lancet 2003, 362, 983-988.
39. Rode, L.; Nordestgaard, B.G.; Weischer, M.; Bojesen, S.E. Increased body mass index, elevated C-reactive protein, and short telomere length. J. Clin. Endocrinol. Metab. 2014, 99, E1671-E1675.
40. Harte, A.L.; da Silva, N.F.; Miller, M.A.; Cappuccio, F.P.; Kelly, A.; O’Hare, J.P.; Barnett, A.H.; Al-Daghri, N.M.; Al-Attas, O.; Alokail, M.; et al. Telomere length attrition, a marker of biological senescence, is inversely correlatedwith triglycerides and cholesterol in southAsianmaleswith type 2 dibatesmellitus. Exp. Diabetes Res. 2012, 895185.
41. Salpea, K.D.; Humphries, S.E. Telomeres length in atherosclerosis and diabetes. Atherosclerosis 2010, 209, 35-38.
42. Cassidy, A.; De Vivo, I.; Liu, Y.; Han, J.; Prescott, J.; Hunter, D.J.; Rimm, E.B. Associations between diet, lifestyle factors, and telomere length in women. Am. J. Clin. Nutr. 2010, 91, 1273-1280.
43. O’Callaghan, N.J.; Clifton, P.M.; Noakes, M.; Fenech, M. Weight loss in obese men is associated with increased telomere length and decreased abasic sites in rectal mucosa. Rejuvenation Res. 2009, 12, 169-176.
44. Formichi, C.; Cantara, S.; Ciuoli, C.; Neri, O.; Chiofalo, F.; Selmi, F.; Tirone, A.; Colasanto, G.; Di Cosmo, L.; Vuolo, G.; et al. Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 Year. Obes. Surg. 2014, 24, 2089-2093.
45. Epel, E.S. Psychological and metabolic stress: A recipe for accelerated cellular aging? Hormones 2009, 8, 7-22.
46. Laimer, M.; Melmer, A.; Lamina, C.; Raschenberger, J.; Adamovski, P.; Engl, J.; Ress, C.; Tschoner, A.; Gelsinger, C.; Mair, L.; et al. Telomere length increase after weight loss induced by bariatric surgery: Results from a 10 year prospective study. Int. J. Obes. 2016, 40, 773-778.
47. Carulli, L.; Anzivino, C.; Baldelli, E.; Zenobii, M.F.; Rocchi, M.B.; Bertolotti, M. Telomere length elongation after weight loss intervention in obese adults. Mol. Genet. Metab. 2016, 118, 138-142.
48. Bernstein, B.E.; Meissner, A.; Lander, E.S. The mammalian epigenome. Cell 2007, 128, 669-681.
49. Fan, S.; Zhang, X. CpG island methylation pattern in different human tissues and its correlation with gene expression. Biochem. Biophys. Res. Commun. 2009, 383, 421-425.
50. Franks, P.W.; Ling, C. Epigenetics and obesity: The devil is in the details. BMC Med. 2010, 8, 88.
51. Udali, S.; Guarini, P.; Moruzzi, S.; Choi, S.W.; Friso, S. Cardiovascular epigenetics: From DNA methylation to microRNAs. Mol. Asp. Med. 2013, 34, 883-901.
52. Choi, S.W.; Friso, S. Epigenetics: A new bridge between nutrition and health. Adv. Nutr. 2010, 1, 8-16.
53. Saetrom, P.; Snove O.; Jr.; Rossi, J.J. Epigenetics and microRNAs. Pediatr. Res. 2007, 61, 17R-23R.
54. Campión, J.; Milagro, F.; Martínez, J.A. Epigenetics and obesity. Prog. Mol. Biol. Transl. Sci. 2010, 94, 291-347.
55. Duthie, S.J. Epigenetic modifications and human pathologies: Cancer and CVD. Proc. Nutr. Soc. 2011, 70, 47-56.
56. Ramos-Lopez, O.; Milagro, F.I.; Allayee, H.; Chmurzynska, A.; Choi, M.S.; Curi, R.; De Caterina, R.; Ferguson, L.R.; Goni, L.; Kang, J.X.; et al. Guide for current nutrigenetic, nutrigenomic, and nutriepigenetic approaches for precision nutrition involving the prevention and management of chronic diseases associated with obesity. J. Nutrigenet. Nutrigenom. 2017, 10, 43-62.
57. Boqué, N.; de la Iglesia, R.; de la Garza, A.L.; Milagro, F.I.; Olivares, M.; Bañuelos, O.; Soria, A.C.; Rodríguez-Sánchez, S.; Martínez, J.A.; Campión, J. Prevention of diet-induced obesity by apple polyphenols inWistar rats through regulation of adipocyte gene expression and DNA methylation patterns. Mol. Nutr. Food Res. 2013, 57, 1473-1478.
58. Uriarte, G.; Paternain, L.; Milagro, F.I.; Martínez, J.A.; Campion, J. Shifting to a control diet after a high-fat, highsucrose diet intake induces epigenetic changes in retroperitoneal adipocytes of Wistar rats. J. Physiol. Biochem. 2013, 69, 601-611.
59. Milagro, F.I.; Campión, J.; Cordero, P.; Goyenechea, E.; Gómez-Uriz, A.M.; Abete, I.; Zulet, M.A.; Martínez, J.A. A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. FASEB J. 2011, 25, 1378-1389.
60. Cordero, P.; Campion, J.; Milagro, F.I.; Goyenechea, E.; Steemburgo, T.; Javierre, B.M.; Martinez, J.A. Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J. Physiol. Biochem. 2011, 67, 463-470.
61. Crujeiras, A.B.; Campion, J.; Díaz-Lagares, A.; Milagro, F.I.; Goyenechea, E.; Abete, I.; Casanueva, F.F.; Martínez, J.A. Association of weight regain with specific methylation levels in the NPY and POMC promoters in leukocytes of obese men: A translational study. Regul. Pept. 2013, 186, 1-6.
62. Nicoletti, C.F.; Nonino, C.B.; de Oliveira, B.A.; Pinhel, M.A.; Mansego, M.L.; Milagro, F.I.; Zulet, M.A.; Martinez, J.A. DNA methylation and hydroxymethylation levels in relation to two weight loss strategies: Energy-restricted diet or bariatric surgery. Obes. Surg. 2016, 26, 603-611.
63. Barres, R.; Kirchner, H.; Rasmussen, M.; Yan, J.; Kantor, F.R.; Krook, A.; Näslund, E.; Zierath, J.R. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 2013, 3, 1020-1027.
64. Falken, Y.; Hellstrom, P.M.; Holst, J.J.; Naslund, E. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: Role of gut peptides. J. Clin. Endocrinol. Metab. 2011, 96, 2227-2235.
65. Rubino, F.; Forgione, A.; Cummings, D.E.; Vix, M.; Gnuli, D.; Mingrone, G.; Castagneto, M.; Marescaux, J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann. Surg. 2006, 244, 741-749.
66. Kirchner, H.; Nylen, C.; Laber, S.; Barrès, R.; Yan, J.; Krook, A.; Zierath, J.R.; Näslund, E. Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass. Surg. Obes. Relat. Dis. 2014, 10, 671-678.
67. Morcillo, S.; Martín-Núñez, G.M.; García-Serrano, S.; Gutierrez-Repiso, C.; Rodriguez-Pacheco, F.; Valdes, S.; Gonzalo, M.; Rojo-Martinez, G.; Moreno-Ruiz, F.J.; Rodriguez-Cañete, A.; et al. Changes in SCD gene DNA methylation after bariatric surgery in morbidly obese patients are associated with free fatty acids. Sci. Rep. 2017, 7, 46292.
68. Nilsson, E.K.; Ernst, B.; Voisin, S.; Almén, M.S.; Benedict, C.; Mwinyi, J.; Fredriksson, R.; Schultes, B.; Schiöth, H.B. Rouxen-Y gastric bypass surgery induces genome-wide promoter-specific changes in DNA methylation in whole blood of obese patients. PLoS ONE 2015, 10, e0115186.
69. Ahrens, M.; Ammerpohl, O.; von Schönfels, W.; Kolarova, J.; Bens, S.; Itzel, T.; Teufel, A.; Herrmann, A.; Brosch, M.; Hinrichsen, H.; et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab. 2013, 18, 296-302.
70. Benton, M.C.; Johnstone, A.; Eccles, D.; Harmon, B.; Hayes, M.T.; Lea, R.A.; Griffiths, L.; Hoffman, E.P.; Stubbs, R.S.; Macartney-Coxson, D.An analysis ofDNAmethylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass andweight loss. Genome Biol. 2015, 16, 8.
71. Martín-Núñez, G.M.; Cabrera-Mulero, A.; Alcaide-Torres, J.; García-Fuentes, E.; Tinahones, F.J.; Morcillo, S. No effect of different bariatric surgery procedures on LINE-1 DNA methylation in diabetic and nondiabetic morbidly obese patients. Surg. Obes. Relat. Dis. 2017, 13, 442-450.
72. Van Dijk, S.J.; Molloy, P.L.; Varinli, H.; Morrison, J.L.; Muhlhausler, B.S. Epigenetics and human obesity. Int. J. Obes. 2015, 39, 85-97.
73. Guénarda, F.; Deshaiesb, Y.; Cianfloneb, K.; Krald, J.G.; Marceauc, P.; Vohla, M.C. Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc. Natl. Acad. Sci. USA 2013, 110, 11439-11444.
74. Donkin, I.; Versteyhe, S.; Ingerslev, L.R.; Qian, K.; Mechta, M.; Nordkap, L.; Mortensen, B.; Appel, E.V.; Jørgensen, N.; Kristiansen, V.B.; et al. Obesity and bariatric surgery drive epigenetic variation of spermatozoa in humans. Cell Metab. 2016, 23, 369-378.
75. Dedeurwaerder, S.; Defrance, M.; Calonne, E.; Denis, H.; Sotiriou, C.; Fuks, F. Evaluation of the infinium methylation 450K technology. Epigenomics 2011, 3, 771-784.
76. Ferguson, L.R. Nutrigenomics approaches to functional foods. J. Am. Diet. Assoc. 2009, 109, 452-458.
77. Mutch, D.M.; Temanni, M.R.; Henegar, C.; Combes, F.; Pelloux, V.; Holst, C.; Sørensen, T.I.; Astrup, A.; Martinez, J.A.; Saris, W.H.; et al. Adipose gene expression prior to weight loss can differentiate and weakly predict dietary responders. PLoS ONE 2007, 2, e1344.
78. Cortes-Oliveira, C.; Nicoletti, C.F.; Pinhel, M.A.S.; Oliveira, B.A.P.; Quinhoneiro, D.C.G.; Noronha, N.Y.; Marchini, J.S.; da Silva Júnior, W.A.; Júnior, W.S.; Nonino, C.B. UCP2 expression is associated with weight loss after hypocaloric diet intervention. Eur. J. Clin. Nutr. 2016, 1-5.
79. Cortes-Oliveira, C.; Nicoletti, C.F.; Pinhel, M.A.S.; Oliveira, B.A.P.; Quinhoneiro, D.C.G.; Noronha, N.Y.; Fassini, P.G.; Marchini, J.S.; da Silva Júnior, W.A.; Salgado Júnior, W.; et al. Influence of expression of UCP3, PLIN1 and PPARG2 on the oxidation of substrates after hypocaloric dietary intervention. Clin. Nutr. 2017, 1-6.
80. Ordovás, J.M.; Robertson, R.; Cléirigh, E.N. Gene-gene and gene-environment interactions defining lipid-related traits. Curr. Opin. Lipidol. 2011, 22, 129-136.
81. Pinhel, M.A.S.; Nicoletti, C.F.; Noronha, N.Y.; Oliveira, B.A.P.; Quinhoneiro, D.C.G.; Cortes-Oliveira, C.; Salgado, W.; Jr.; Salgado Junior, W.; Machry, A.J.; da Silva Junior, W.A.; Souza, D.R.S.; et al. Changes in global transcriptional profiling of women following obesity surgery bypass. Obes. Surg. 2017.
82. Berisha, S.Z.; Serre, D.; Schauer, P.; Kashyap, S.R.; Smith, J.D. Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: A pilot study. PLoS ONE 2011, 6, e16729.
83. Ortega, F.J.; Vilallonga, R.; Xifra, G.; Sabater, M.; Ricart, W.; Fernández-Real, J.M. Bariatric surgery acutely changes the expression of inflammatory and lipogenic genes in obese adipose tissue. Surg. Obes. Relat. Dis. 2016, 12, 357-362.
84. Mardinoglu, A.; Heiker, J.T.; Gärtner, D.; Björnson, E.; Schön, M.R.; Flehmig, G.; Klöting, N.; Krohn, K.; Fasshauer, M.; Stumvoll, M.; et al. Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue. Sci. Rep. 2015, 5, 14841.
85. Oliveira, B.A.P.; Pinhel, M.A.S.; Nicoletti, C.F.; Cortes-Oliveira, C.; Quinhoneiro, D.C.G.; Noronha, N.Y.; Fassini, P.G.; da Silva Júnior, W.A.; Junior, W.S.; Nonino, C.B. UCP2 and PLIN1 expression affects the resting metabolic rate and weight loss on obese patients. Obes. Surg. 2016, 27, 343-348.
86. Jürets, A.; Itariu, B.K.; Keindl, M.; Prager, G.; Langer, F.; Grablowitz, V.; Zeyda, M.; Stulnig, T.M. Upregulated TNF expression 1 year after bariatric surgery reflects a cachexia-like state in subcutaneous adipose tissue. Obes. Surg. 2017, 27, 1514-1523.
87. Leyvraz, C.; Verdumo, C.; Suter, M.; Paroz, A.; Calmes, J.M.; Marques-Vidal, P.M.; Giusti, V. Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss. Obes. Facts 2012, 5, 440-451.
88. Oliveira, B.A.P.; Pinhel, M.A.S.; Nicoletti, C.F.; Cortes-Oliveira, C.; Quinhoneiro, D.C.G.; Noronha, N.Y.; Marchini, J.S.; Marchry, A.J.; Junior, W.S.; Nonino, C.B. UCP1 and UCP3 expression is associated with lipid and carbohydrate oxidation and body composition. PLoS ONE 2016.
89. Hagman, D.K.; Larson, I.; Kuzma, J.N.; Cromer, G.; Makar, K.; Rubinow, K.B.; Foster-Schubert, K.E.; van Yserloo, B.; Billing, P.S.; Landerholm, R.W.; et al. The short-termand long-termeffects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans. Metabolism 2017, 70, 12-22.
90. Anhê, F.F.; Varin, T.V.; Schertzer, J.D.; Marette, A. The gut microbiota as a mediator of metabolic benefits after bariatric surgery. Can. J. Diabetes 2017, 30521-30524.
91. Tremaroli, V.; Karlsson, F.; Werling, M.; Ståhlman, M.; Kovatcheva-Datchary, P.; Olbers, T.; Fändriks, L.; le Roux, C.W.; Nielsen, J.; Bäckhed, F. Roux-en-Y gastric bypass and verticalbandedgastroplasty induce long-term changes on the human gutmicrobiome contributing to fat mass regulation. Cell Metab. 2015, 22, 228-238.
92. Liou, A.P.; Paziuk, M.; Luevano, J.M.; Jr.; Machineni, S.; Turnbaugh, P.J.; Kaplan, L.M. Conserved shifts in the gut microbiotadue to gastric bypass reduce host weight and adiposity. Sci. Transl. Med. 2013, 5.
93. Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; Shen, D.; et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55-60.
94. Palleja, A.; Kashani, A.; Allin, K.H.; Nielsen, T.; Zhang, C.; Li, Y.; Brach, T.; Liang, S.; Feng, Q.; Jørgensen, N.B.; et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016, 8, 67.
95. Zhang, H.; DiBaise, J.K.; Zuccolo, A.; Kudrna, D.; Braidotti, M.; Yu, Y.; Parameswarana, P.; Crowellb, M.D.; Wingc, R.; Rittmann, B.E.; et al. Human gutmicrobiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. USA 2009, 106, 2365-2370.
96. Graessler, J.; Qin, Y.; Zhong, H.; Zhang, J.; Licinio, J.; Wong, M.L.; Xu, A.; Chavakis, T.; Bornstein, A.B.; Ehrhart-Bornstein, M.; et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: Correlation with inflammatory and metabolic parameters. Pharmacogenom. J. 2013, 13, 514-522.
97. Kong, L.C.; Tap, J.; Aron-Wisnewsky, J.; Pelloux, V.; Basdevant, A.; Bouillot, J.L.; Zucker, J.D.; Doré, J.; Clément, K. Gut microbiota after gastric bypass in human obesity: Increased richness and associations of bacterial genera with adipose tissue genes. Am. J. Clin. Nutr. 2013, 98, 16-24.
98. Furet, J.P.; Kong, L.C.; Tap, J.; Poitou, C.; Basdevant, A.; Bouillot, J.L.; Mariat, D.; Corthier, G.; Doré, J.; Henegar, C.; et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and lowgrade inflammation markers. Diabetes 2010, 59, 3049-3057.